Completed
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
NCT00343486
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- GSK Investigational Site Av Córdoba 2424, Buenos Aires, Argentina
- GSK Investigational Site Bahía Blanca, Buenos Aires, Argentina
- GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina